AHB
Abner Herrman & Brock’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,225
| Closed | -$675K | – | 67 |
|
|
2024
Q3 | $675K | Sell |
10,225
-1,206
| -11% | -$79.6K | 0.08% | 61 |
|
|
2024
Q2 | $1.06M | Sell |
11,431
-760
| -6% | -$70.2K | 0.13% | 55 |
|
|
2024
Q1 | $1.17M | Sell |
12,191
-2
| -0% | -$191 | 0.15% | 53 |
|
|
2023
Q4 | $930K | Sell |
12,193
-19,737
| -62% | -$1.51M | 0.13% | 56 |
|
|
2023
Q3 | $2.21M | Sell |
31,930
-7,019
| -18% | -$486K | 0.34% | 50 |
|
|
2023
Q2 | $3.67M | Sell |
38,949
-1,237
| -3% | -$117K | 0.54% | 42 |
|
|
2023
Q1 | $3.33M | Sell |
40,186
-1,835
| -4% | -$152K | 0.5% | 43 |
|
|
2022
Q4 | $3.14M | Sell |
42,021
-12,061
| -22% | -$900K | 0.48% | 44 |
|
|
2022
Q3 | $4.47M | Buy |
54,082
+790
| +1% | +$65.3K | 0.82% | 37 |
|
|
2022
Q2 | $5.07M | Buy |
53,292
+150
| +0.3% | +$14.3K | 0.87% | 36 |
|
|
2022
Q1 | $6.26M | Buy |
53,142
+2,405
| +5% | +$283K | 0.88% | 34 |
|
|
2021
Q4 | $6.57M | Buy |
50,737
+3,003
| +6% | +$389K | 0.86% | 37 |
|
|
2021
Q3 | $5.4M | Buy |
47,734
+1,393
| +3% | +$158K | 0.76% | 38 |
|
|
2021
Q2 | $4.8M | Buy |
46,341
+3,280
| +8% | +$340K | 0.67% | 41 |
|
|
2021
Q1 | $3.6M | Sell |
43,061
-24,610
| -36% | -$2.06M | 0.54% | 42 |
|
|
2020
Q4 | $6.17M | Sell |
67,671
-13,284
| -16% | -$1.21M | 0.96% | 35 |
|
|
2020
Q3 | $6.46M | Buy |
80,955
+25,465
| +46% | +$2.03M | 1.09% | 32 |
|
|
2020
Q2 | $3.84M | Buy |
55,490
+36,865
| +198% | +$2.55M | 0.69% | 40 |
|
|
2020
Q1 | $3.51M | Sell |
18,625
-553
| -3% | -$104K | 0.8% | 36 |
|
|
2019
Q4 | $4.47M | Sell |
19,178
-250
| -1% | -$58.3K | 0.67% | 39 |
|
|
2019
Q3 | $4.27M | Buy |
+19,428
| New | +$4.27M | 0.63% | 37 |
|